Organ Preservation: FDA Weighs Animal Study Questions For Machine Perfusion Devices
Executive Summary
US FDA has drafted a guidance exploring when developers of transplant organ preservation devices should rely on ex vivo versus in vivo animal studies, among other questions.
You may also be interested in...
Animal Trial Procedures Focus Of Transplant-Tech FDA Guidance
New final guidance from the US FDA discusses how to model clinical trials for new organ-preservation devices, including those using animals.
FDA Eyes Upclassification, Labeling Guidance To Address Stapler Risks
The US agency sent a letter to health-care providers spotlighting its analysis of the increasing numbers of adverse events linked to surgical staplers and implantable staples, and its plans for a draft guidance on labeling and an advisory panel meeting to consider a 510(k) requirement for the products.
Device Week, March 8, 2019 – Scott Gottlieb Resigns
On the latest Medtech Insight podcast, David Filmore and Ferdous Al-Faruque discuss the unexpected news that Scott Gottlieb is leaving US FDA next month. What has been his legacy for medtech, and who will replace him?